Literature DB >> 9613947

Determination of fluoxetine and its metabolite norfluoxetine in serum and brain areas using high-performance liquid chromatography with ultraviolet detection.

J C Alvarez1, D Bothua, I Collignon, C Advenier, O Spreux-Varoquaux.   

Abstract

A high-performance liquid chromatography (HPLC) method using only 0.1 ml of serum or homogenate from brain areas has been developed for the determination of fluoxetine (FLU) and its metabolite, norfluoxetine (N-FLU), with ultraviolet detection at 227 nm. The small volume of sample required in this method allows studies in small animals, such as mouse. The method provides recoveries of up to 90% for both compounds. Acceptable coefficients of variation were found for both within-run and day-to-day assays. The limit of detection was 5.0 ng/ml. No interferences were found with tricyclic antidepressant drugs and benzodiazepines, which allows this method to be used in clinical studies, Pharmacokinetic parameters for the two compounds are reported in mouse serum, frontal cortex and caudate nucleus. We also report the values of FLU and N-FLU in serum from humans who were treated once daily with 20 mg of FLU, obtained after 1, 14 and 28 days of treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9613947     DOI: 10.1016/s0378-4347(97)00588-4

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  7 in total

1.  Fluoxetine ameliorates mucopolysaccharidosis type IIIA.

Authors:  Antonella Capuozzo; Sandro Montefusco; Vincenzo Cacace; Martina Sofia; Alessandra Esposito; Gennaro Napolitano; Eduardo Nusco; Elena Polishchuk; Maria Teresa Pizzo; Maria De Risi; Elvira De Leonibus; Nicolina Cristina Sorrentino; Diego Luis Medina
Journal:  Mol Ther       Date:  2022-02-02       Impact factor: 12.910

2.  Prozac during puberty: distinctive effects on neurogenesis as a function of age and sex.

Authors:  G E Hodes; L Yang; J Van Kooy; J Santollo; T J Shors
Journal:  Neuroscience       Date:  2009-07-02       Impact factor: 3.590

3.  Sex-specific effects of chronic fluoxetine treatment on neuroplasticity and pharmacokinetics in mice.

Authors:  Georgia E Hodes; Tiffany E Hill-Smith; Raymond F Suckow; Thomas B Cooper; Irwin Lucki
Journal:  J Pharmacol Exp Ther       Date:  2009-10-14       Impact factor: 4.030

4.  Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat.

Authors:  Judith R Homberg; Jocelien D A Olivier; Tom Blom; Tim Arentsen; Chantal van Brunschot; Pieter Schipper; Gerdien Korte-Bouws; Gilles van Luijtelaar; Liesbeth Reneman
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

5.  Serotonin rebalances cortical tuning and behavior linked to autism symptoms in 15q11-13 CNV mice.

Authors:  Nobuhiro Nakai; Masatoshi Nagano; Fumihito Saitow; Yasuhito Watanabe; Yoshinobu Kawamura; Akiko Kawamoto; Kota Tamada; Hiroshi Mizuma; Hirotaka Onoe; Yasuyoshi Watanabe; Hiromu Monai; Hajime Hirase; Jin Nakatani; Hirofumi Inagaki; Tomoyuki Kawada; Taisuke Miyazaki; Masahiko Watanabe; Yuka Sato; Shigeo Okabe; Kazuo Kitamura; Masanobu Kano; Kouichi Hashimoto; Hidenori Suzuki; Toru Takumi
Journal:  Sci Adv       Date:  2017-06-21       Impact factor: 14.136

6.  Paradoxical anxiogenic response of juvenile mice to fluoxetine.

Authors:  Ji-eun Oh; Bojana Zupan; Steven Gross; Miklos Toth
Journal:  Neuropsychopharmacology       Date:  2009-05-13       Impact factor: 7.853

7.  Corticosterone facilitates fluoxetine-induced neuronal plasticity in the hippocampus.

Authors:  Katsunori Kobayashi; Yumiko Ikeda; Minoru Asada; Hirofumi Inagaki; Tomoyuki Kawada; Hidenori Suzuki
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.